Inspire Medical Systems, Inc. (INSP)

Market Cap	5.89B
Revenue (ttm)	705.71M
Net Income (ttm)	6.01M
Shares Out	29.82M
EPS (ttm)	0.20
PE Ratio	979.47
Forward PE	233.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	372,264
Open	203.38
Previous Close	203.45
Day's Range	197.53 - 203.38
52-Week Range	123.00 - 257.40
Beta	1.34
Analysts	Buy
Price Target	214.25 (+8.47%)
Earnings Date	Nov 4, 2024

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,011
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Financial Performance

In 2023, Inspire Medical Systems's revenue was $624.80 million, an increase of 53.19% compared to the previous year's $407.86 million. Losses were -$21.15 million, -52.87% less than in 2022.

Analyst Forecast

According to 12 analysts, the average rating for INSP stock is "Buy." The 12-month stock price forecast is $214.25, which is an increase of 8.47% from the latest price.

Price Target

$214.25

(8.47% upside)

Analyst Consensus: Buy